This is a non-core endpoint: only basic statistics are computed.
Leiomyosarcoma
C3_LEIOMYOSARCOMA
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
252 |
4. Check minimum number of eventsNone |
252 |
5. Include endpointsNone |
252 |
6. Filter based on genotype QC (FinnGen only) |
245 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Leiomyosarcoma
based on the number of shared cases.
Similar with more cases:
- Leiomyosarcoma, including Hilmo
- Solid cancers, helper endpoint
- Malignant neoplasm
- Any event in cancer register
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 245 | 164 | 81 |
| Unadjusted period prevalence (%) | 0.05 | 0.06 | 0.04 |
| Median age at first event (years) | 59.72 | 57.17 | 64.90 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 252
- Matched controls
- 2520
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
116.7
183.1
95
13
A04AA01
ATC
ondansetron; systemic, rectal
30.3
91.2
64
28
130
Kela drug reimbursment
Malignant tumour
+∞
90.1
81
*
A03FA01
ATC
metoclopramide; systemic, rectal
11.9
87.3
126
195
JN4BD
NOMESCO Finland
Extensive body CT
18.0
83.2
76
59
Z51.5
ICD-10 Finland
Palliative care
23.0
80.2
63
36
C54.21
ICD-10 Finland
Leiomyosarcoma and myometrium
+∞
79.5
72
*
JN4AD
NOMESCO Finland
Body CT examination
15.5
70.2
69
60
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
27.2
63.0
45
20
XX3DW
NOMESCO Finland
Time consuming IT work
15.2
62.5
61
52
WX302
NOMESCO Finland
Thoracal epidural anesthesy
25.2
59.8
44
21
TPX10
NOMESCO Finland
Implantation of vascular injection port
25.7
59.0
43
20
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
366.2
58.9
57
*
L03AA13
ATC
pegfilgrastim; parenteral
647.4
54.7
52
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
49.6
46
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
47.4
44
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
47.4
44
*
8890/3-C54.9
ICD-O-3
Leiomyosarcoma, NOS, of corpus uteri
+∞
43.0
40
*
A04AA02
ATC
granisetron; systemic, transdermal
482.8
42.5
41
*
N02AA05
ATC
oxycodone; systemic
6.2
42.5
100
241
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
16.5
41.6
37
26
B01AB10
ATC
tinzaparin; parenteral
8.1
41.2
65
104
L03AA02
ATC
filgrastim; parenteral
+∞
40.7
38
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
440.8
39.2
38
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
9.9
38.6
49
60
C54.2
ICD-10 Finland
Malignant neoplasm: Myometrium
+∞
38.5
36
*
C49.23
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip leiomyosarcoma
+∞
38.5
36
*
8890/3-C49.2
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
38.5
36
*
159
Kela drug reimbursment
Pazopanib
+∞
38.5
36
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
36.3
34
*
8890/3-C54.2
ICD-O-3
Leiomyosarcoma, NOS, of myometrium
+∞
34.1
32
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
33.0
31
*
WZC00
NOMESCO Finland
Treatment plan or consultation
4.6
31.1
117
402
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
30.9
29
*
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
11.7
30.4
33
32
L02BG04
ATC
letrozole; oral
169.5
29.3
30
*
WZC30
NOMESCO Finland
Teaching
5.5
28.4
66
152
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
163.1
28.3
29
*
LCD00
NOMESCO Finland
Hysterectomy
8.0
27.6
41
60
C48.03
ICD-10 Finland
Malignant tumor of the retroperitoneal space leiomyosarcoma
+∞
27.6
26
*
A04AD12
ATC
aprepitant; systemic
+∞
27.6
26
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
25.4
24
*
B01AB05
ATC
enoxaparin; parenteral
3.9
25.4
129
534
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
24.4
23
*
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
24.4
23
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
7.7
23.2
35
52
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
22.2
21
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
240.0
22.0
22
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.9
21.3
31
44
C49.43
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen leiomyosarcoma
+∞
21.1
20
*
L01XE11
ATC
[U] pazopanib
+∞
21.1
20
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
7.3
21.0
33
51
343
Kela drug reimbursment
Pazopanib
+∞
20.1
19
*
JN4CD
NOMESCO Finland
Very extensive body CT
27.3
20.0
27
11
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
+∞
19.0
18
*
8890/3-C49.1
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
19.0
18
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
8.6
18.6
25
32
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
57.0
18.3
21
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.4
18.1
90
354
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
17.9
17
*
L01EX03
ATC
pazopanib; oral
+∞
17.9
17
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
14.7
17.5
29
22
WF002
NOMESCO Finland
Radical radiotherapy
54.0
17.3
20
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
16.9
16
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
+∞
16.9
16
*
C49.2
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of lower limb, including hip
+∞
16.9
16
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
16.9
16
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
16.9
16
*
ZZR00
NOMESCO Finland
Flap of skin
96.6
16.8
18
*
WW500
NOMESCO Finland
Blood transfusion
15.8
16.8
27
19
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
15.8
16.8
27
19
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
181.5
16.7
17
*
C49.13
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder leiomyosarcoma
+∞
15.8
15
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
15.8
15
*
8890/3-C48.0
ICD-O-3
Leiomyosarcoma, NOS, of retroperitoneum
+∞
15.8
15
*
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
14.3
15.6
26
20
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
34.1
15.0
19
6
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
19.9
15.0
22
12
ZX120
NOMESCO Finland
Intravenous
5.5
15.0
31
63
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
4.1
14.9
47
135
8890/3-C49.4
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
14.7
14
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
14.7
14
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
11.1
14.4
27
27
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
14.1
143
810
TPH07
NOMESCO Finland
Cathetrisation of artery
3.9
14.1
46
135
ZX090
NOMESCO Finland
Other technic of radiotherapy
56.7
14.0
16
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
36.3
13.7
17
5
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
13.7
13
*
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
+∞
13.7
13
*
C49.53
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis leiomyosarcoma
+∞
13.7
13
*
A79
ICPC
Malignancy NOS
+∞
13.7
13
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
13.6
63
233
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
12.6
12
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
12.6
12
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
12.6
12
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
12.6
12
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
12.6
12
*
B01AB04
ATC
dalteparin; parenteral
5.8
12.6
24
45
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
4.0
12.0
37
104
WX402
NOMESCO Finland
General anaesthesia
3.1
11.9
59
226
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
68.2
11.7
13
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.1
11.7
35
96
115
Kela drug reimbursment
Breast cancer
+∞
11.5
11
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.5
11.5
44
143
JAH00
NOMESCO Finland
Laparotomy
10.4
11.5
22
23
R50.9
ICD-10 Finland
Fever, unspecified
3.2
11.0
51
187
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
10.5
10
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
10.5
10
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
10.5
10
*
C54.12
ICD-10 Finland
Adenosquamous carcinoma of the endometrium
+∞
10.5
10
*
8890/3-C55.9
ICD-O-3
Leiomyosarcoma, NOS, of uterus, NOS
+∞
10.5
10
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
10.5
10
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
10.5
10
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
10.5
10
*
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
+∞
10.5
10
*
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.9
10.5
24
53
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
24.6
10.4
14
6
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
13.9
10.3
17
13
S18
ICPC
Laceration/cut
2.4
10.1
133
812
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
11.3
10.0
18
17
ZXE20
NOMESCO Finland
More than three and less than five hours
3.1
9.9
47
174
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
57.3
9.7
11
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
9.6
105
588
ZXE30
NOMESCO Finland
More than five and less than seven hours
7.4
9.6
22
32
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
18.4
9.5
14
8
PJA12
NOMESCO Finland
Sentinel node biopsy
103.8
9.5
10
*
C54.9
ICD-10 Finland
Malignant neoplasm: Corpus uteri, unspecified
+∞
9.4
9
*
X77
ICPC
Malignant neopl genital female other
+∞
9.4
9
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
9.4
9
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
9.4
9
*
C49.83
ICD-10 Finland
Overall malignant tumor of connective tissue and other soft tissue leiomyosarcoma
+∞
9.4
9
*
C49.33
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the chest leiomyosarcoma
+∞
9.4
9
*
C49.03
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck Leiomyosarcoma
+∞
9.4
9
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
9.4
9
*
SPAT1255
SPAT
Intravenous administration of medicine
4.2
9.4
26
67
JN3AD
NOMESCO Finland
Abdominal CT examination
3.2
9.4
40
139
GD1AD
NOMESCO Finland
Thorax CT examination
4.6
9.1
22
51
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
8.9
55
235
C03CA01
ATC
furosemide; systemic
2.3
8.9
105
604
M05BX04
ATC
denosumab; parenteral
3.8
8.7
28
81
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
93.0
8.5
9
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
9.0
8.5
17
20
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
10.0
8.4
16
17
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
8.4
8
*
NGR30
NOMESCO Finland
Extensive or radikal excision of tumor of knee or lower leg
+∞
8.4
8
*
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
+∞
8.4
8
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
8.4
8
*
KAC00
NOMESCO Finland
Nephrectomy
+∞
8.4
8
*
1820C
ICD-9 Finland
Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[SARCOMA MYOMETRI]
+∞
8.4
8
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
8.4
8
*
8890/3-C49.5
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of pelvis
+∞
8.4
8
*
A06AH03
ATC
naloxegol; oral
34.6
8.1
10
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
8.9
7.9
16
19
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.1
7.9
22
57
SPAT1153
SPAT
Removal of sutures
2.2
7.8
93
531
WX306
NOMESCO Finland
Lumbar epidural anesthesy
4.2
7.8
21
53
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.6
7.8
27
82
JFB30
NOMESCO Finland
Right hemicolectomy
46.4
7.8
9
*
ZZA00
NOMESCO Finland
Split skin graft
9.3
7.7
15
17
B02AA02
ATC
tranexamic acid; systemic
2.6
7.6
50
219
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.9
7.6
38
144
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
10.5
7.6
14
14
JAL00
NOMESCO Finland
Biopsy of peritoneum
25.9
7.6
10
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
6.8
7.6
18
28
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.6
7.5
26
79
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
82.4
7.5
8
*
8890/3-C64.9
ICD-O-3
Leiomyosarcoma, NOS, of kidney, NOS
+∞
7.3
7
*
8890/3-C49.6
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
7.3
7
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
7.3
7
*
YJ1CD
NOMESCO Finland
Very extensive CT examination of abdomen for dose design of radiotherapy
+∞
7.3
7
*
C54.29
ICD-10 Finland
Unspecified uterine sarcoma
+∞
7.3
7
*
8890/3-C44.6
ICD-O-3
Leiomyosarcoma, NOS, of skin of upper limb and shoulder
+∞
7.3
7
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
7.3
7
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
7.3
7
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
+∞
7.3
7
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
7.3
7
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
7.3
7
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
7.3
7
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
7.3
7
*
8890/3-C44.7
ICD-O-3
Leiomyosarcoma, NOS, of skin of lower limb and hip
+∞
7.3
7
*
L02AB02
ATC
medroxyprogesterone; systemic
41.2
6.8
8
*
JFB00
NOMESCO Finland
Partial resection of small intestine
23.2
6.7
9
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.8
6.7
36
142
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
2.9
6.7
34
130
UKC02
NOMESCO Finland
Cystoscopy
2.5
6.6
44
194
J01MA12
ATC
levofloxacin; systemic
2.4
6.5
53
256
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
71.6
6.5
7
*
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
71.6
6.5
7
*
KBV00
NOMESCO Finland
Insertion of stent into ureter
71.6
6.5
7
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
71.6
6.5
7
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
9.6
6.4
12
13
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
5.3
6.3
18
36
N07BC02
ATC
methadone; systemic
+∞
6.3
6
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
6.3
6
*
C48.02
ICD-10 Finland
Malignant tumor of the retroperitoneal space liposarcoma
+∞
6.3
6
*
C48.0
ICD-10 Finland
Malignant neoplasm: Retroperitoneum
+∞
6.3
6
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
6.3
6
*
C49.10
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder without histology
+∞
6.3
6
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
6.3
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
+∞
6.3
6
*
C48.09
ICD-10 Finland
Malignant tumor of the retroperitoneal space other or unspecified tumor
+∞
6.3
6
*
C49.63
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the torso, unspecified localization leiomyosarcoma
+∞
6.3
6
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
6.3
6
*
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
27.4
6.3
8
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.4
6.2
45
207
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
52
98
6.43
27.69
2.2
1.5
2.62
2.53
ug/l
0.08
35
75
165
828
3.88
23.83
3.7
2.4
—
—
—
0
0
184
1036
3.88
21.36
20.6
6.1
4.10
4.26
e9/l
0.32
168
900
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
32
50
7.19
20.17
2.6
2.7
0.36
0.36
u/ml
0.00
16
30
102
427
3.33
18.57
3.3
2.1
—
—
—
0
0
155
843
3.18
17.78
7.8
3.7
34.07
35.45
g/l
1.97
146
787
166
962
3.13
16.60
8.9
6.1
1.20
1.22
mmol/l
1.60
135
836
155
877
2.99
15.96
8.6
5.7
1.21
1.22
mmol/l
0.79
147
780
157
952
2.72
13.23
18.2
16.2
1.37
1.31
inr
0.29
48
256
37
102
4.08
12.30
8.1
6.0
24.48
25.50
mmol/l
0.88
37
102
39
115
3.83
11.80
9.5
8.7
95.48
92.83
%
3.04
39
115
22
44
5.38
10.73
1.9
1.3
—
—
—
0
0
69
305
2.74
10.60
2.1
1.8
—
—
—
0
0
38
120
3.55
10.37
1.9
1.6
—
—
—
0
0
65
286
2.72
10.02
4.9
1.7
30.53
29.62
s
0.42
65
278
20
40
5.34
9.74
1.9
1.4
68.48
66.44
pmol/l
0.05
20
40
53
220
2.78
9.08
7.4
8.7
0.42
1.92
mmol/l
2.50
38
182
116
699
2.22
8.72
3.8
3.0
—
—
—
0
0
200
1515
2.55
8.52
18.9
5.1
93.36
77.56
u/l
4.31
194
1388
181
1314
2.34
8.47
6.0
4.5
196.00
4034.23
e6/l
—
7
22
111
668
2.18
8.26
10.0
2.1
2.35
2.35
mmol/l
0.04
103
564
48
199
2.74
8.20
6.5
3.2
—
—
—
0
0
77
403
2.31
8.02
6.6
2.2
2.46
2.44
mmol/l
1.12
70
350
14
16
9.19
7.15
1.6
1.4
3.27
233.87
u/ml
0.48
14
16
49
220
2.52
7.10
1.8
1.8
—
—
—
0
0
90
533
2.07
6.70
3.5
2.9
0.54
0.49
e6/l
0.06
74
395
48
220
2.46
6.64
1.9
1.8
—
—
—
0
0
14
21
6.99
6.12
4.1
3.3
56.79
61.48
%
0.36
14
21
11
11
10.39
6.09
1.6
1.5
—
—
—
0
0
98
619
1.95
5.97
6.6
2.6
45.49
31.61
u/l
1.02
92
589
13
21
6.46
5.46
1.7
1.2
—
—
—
0
0
13
21
6.46
5.46
4.0
2.4
3.33
5.18
e9/l
1.11
13
21
62
342
2.08
5.45
3.1
2.6
1.11
1.31
e6/l
0.34
41
183
8
5
16.45
5.44
2.6
1.4
24.37
14.22
ug/l
—
8
5
11
14
8.16
5.40
1.6
1.4
—
—
—
0
0
5
0
+∞
5.22
3.0
0.0
—
—
—
0
0
29
117
2.67
5.18
1.4
1.4
—
—
—
0
0
15
40
3.92
5.17
1.5
1.3
—
—
—
0
0
14
27
5.42
5.16
1.6
1.2
—
—
—
0
0
57
313
2.06
5.05
3.5
2.8
4.38
3.46
e6/l
0.25
35
154
15
41
3.83
5.00
4.4
2.8
4.71
5.09
kpa
1.12
15
41
12
20
6.24
4.97
1.4
1.1
—
—
—
0
0
8
7
11.75
4.81
2.0
1.7
—
—
—
0
0
8
7
11.75
4.81
1.5
1.1
—
—
—
0
0
15
35
4.49
4.71
1.5
1.2
—
—
—
0
0
12
22
5.67
4.66
1.4
1.2
—
—
—
0
0
11
18
6.34
4.65
1.2
1.2
—
—
—
0
0
11
19
6.00
4.49
1.5
1.2
—
—
—
0
0
95
640
1.78
4.47
2.9
3.1
2590.42
1540.48
ng/l
1.01
84
535
7
6
11.95
4.30
1.6
1.2
—
—
—
0
0
7
6
11.95
4.30
1.6
1.2
—
—
—
0
0
12
25
4.98
4.24
1.4
1.2
—
—
—
0
0
47
256
2.03
4.22
3.0
2.6
20.80
23.58
%
0.91
41
220
6
5
12.24
3.78
1.2
1.6
—
—
—
0
0
38
203
2.03
3.59
3.6
3.1
2.20
2.40
mmol/l
0.12
31
173
25
115
2.30
3.42
2.3
1.7
—
—
—
0
0
18
71
2.65
3.38
2.6
1.7
—
—
—
0
0
6
7
8.74
3.28
2.8
2.1
—
—
—
0
0
7
11
6.51
3.20
1.3
1.2
—
—
—
0
0
5
5
10.16
2.99
1.0
1.2
—
0.59
—
0
5
5
5
10.16
2.99
4.2
1.0
7.26
4.54
nmol/l
—
5
5
75
529
1.59
2.77
4.6
4.0
0.00
0.00
estimate
-0.00
25
164
32
178
1.91
2.71
1.9
3.9
158.68
248.11
ng/l
0.76
25
161
14
55
2.64
2.66
2.0
3.4
—
—
—
0
0
125
997
1.50
2.61
4.0
3.8
0.00
0.01
estimate
0.50
28
180
6
11
5.56
2.56
2.0
2.5
—
—
—
0
0
125
1003
1.49
2.50
5.3
5.3
0.00
0.00
estimate
-0.00
27
162
221
2010
1.81
2.49
31.7
12.9
31.37
21.86
mg/l
3.54
208
1543
12
45
2.75
2.49
1.5
1.4
—
—
—
0
0
126
1016
1.48
2.44
4.1
3.8
0.00
0.02
estimate
0.50
26
162
19
355
0.50
2.30
1.4
1.3
26.09
11.92
u/ml
0.28
11
135
6
13
4.70
2.28
1.2
1.0
—
—
—
0
0
7
18
3.97
2.27
1.3
1.1
—
—
—
0
0
7
18
3.97
2.27
1.1
1.1
—
—
—
0
0
7
18
3.97
2.27
1.3
1.1
—
—
—
0
0
7
18
3.97
2.27
1.3
1.1
—
—
—
0
0
7
18
3.97
2.27
1.3
1.1
—
—
—
0
0
7
18
3.97
2.27
1.3
1.1
—
—
—
0
0
37
563
0.60
2.20
1.5
1.6
1.37
1.36
mmol/l
0.04
28
473
0
56
0.00
2.09
0.0
1.3
—
54.46
—
0
5
68
498
1.50
2.07
2.0
2.2
3.02
3.06
mg/l
0.05
58
425
12
50
2.47
2.06
1.3
1.8
—
—
—
0
0
15
70
2.22
2.02
2.6
1.6
—
—
—
0
0
208
1896
1.56
1.91
33.1
11.6
76.54
76.55
ml/min/173m2
0.00
196
1507
148
1273
1.39
1.81
4.4
3.0
72.18
46.63
u/l
2.08
140
1177
6
18
3.39
1.75
2.3
1.2
—
—
—
0
0
25
150
1.74
1.71
5.0
1.8
60.50
63.67
ml/min/173m2
0.17
14
54
6
19
3.21
1.67
1.0
1.1
—
—
—
0
0
24
376
0.60
1.59
1.3
1.3
15.89
33.89
iu/ml
—
7
120
5
15
3.38
1.53
1.2
1.7
—
—
—
0
0
5
15
3.38
1.53
1.2
1.7
—
—
—
0
0
103
853
1.35
1.52
4.2
3.9
28.99
74.65
ng/l
0.61
88
621
9
38
2.42
1.47
1.2
1.2
—
—
—
0
0
9
40
2.30
1.41
1.3
1.3
—
—
—
0
0
9
40
2.30
1.41
1.3
1.3
—
—
—
0
0
53
401
1.41
1.35
3.9
4.4
25.28
262.20
ng/l
1.50
46
327
56
430
1.39
1.31
1.9
1.7
2.18
1.02
mg/l
1.53
42
336
197
2096
0.72
1.26
4.5
5.3
2.60
2.74
mmol/l
1.23
176
1929
0
35
0.00
1.16
0.0
1.3
—
—
—
0
0
5
20
2.53
1.15
1.2
1.3
—
—
—
0
0
14
81
1.77
1.11
5.2
2.3
504.00
829.15
ug/l
0.25
14
75
7
31
2.29
1.11
1.6
1.1
—
—
—
0
0
17
105
1.66
1.09
3.1
2.0
0.59
0.66
%
0.48
17
105
194
2055
0.76
1.03
4.0
4.7
4.51
4.69
mmol/l
1.52
175
1901
9
47
1.95
1.03
1.4
1.9
—
—
—
0
0
10
53
1.92
1.02
1.3
1.1
—
—
—
0
0
92
786
1.27
1.01
4.8
3.9
—
—
—
0
0
192
2034
0.76
0.99
4.0
4.7
1.49
1.53
mmol/l
0.57
171
1878
17
108
1.62
0.99
3.1
2.0
1.24
1.16
%
0.13
17
108
29
210
1.43
0.96
1.6
2.7
13.33
8.29
ug/l
0.21
22
180
6
28
2.17
0.92
1.3
1.5
—
—
—
0
0
6
28
2.17
0.92
1.2
1.2
—
—
—
0
0
6
28
2.17
0.92
1.3
1.0
—
—
—
0
0
36
276
1.36
0.87
6.3
7.3
—
—
—
0
0
184
1949
0.79
0.85
6.4
6.0
43.27
40.35
mmol/mol
2.25
162
1814
0
27
0.00
0.78
0.0
1.1
—
6.97
—
0
18
21
286
0.71
0.75
1.6
1.4
—
—
—
0
0
9
144
0.61
0.72
1.6
1.7
—
—
—
0
0
171
1601
1.21
0.71
4.6
4.1
14.95
14.86
pmol/l
0.19
160
1453
11
69
1.62
0.69
1.1
1.2
—
—
—
0
0
11
69
1.62
0.69
1.1
1.2
—
—
—
0
0
10
62
1.64
0.66
1.2
1.5
—
—
—
0
0
8
129
0.61
0.66
1.4
1.5
—
—
—
0
0
10
152
0.64
0.63
2.2
1.7
—
—
—
0
0
6
39
1.55
0.53
1.5
1.8
—
—
—
0
0
53
457
1.20
0.53
1.6
1.7
503.11
460.53
pmol/l
0.22
38
374
188
1949
0.86
0.44
3.8
4.3
1.34
1.27
mmol/l
0.72
165
1784
77
844
0.87
0.42
2.4
2.3
76.43
78.45
nmol/l
0.30
68
740
0
16
0.00
0.41
0.0
2.5
—
13.76
—
0
16
8
61
1.32
0.40
5.5
1.4
—
1.28
—
0
6
39
448
0.85
0.39
1.9
1.7
1411.20
1163.89
nmol/l
0.79
25
343
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.0
—
43.25
—
0
12
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.0
—
517.00
—
0
12
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
5
79
0.63
0.36
1.0
1.9
28.00
39.86
u/l
—
5
69
58
525
1.14
0.33
2.7
2.3
344.14
8645.68
umol/l
2.72
50
459
199
2041
0.88
0.31
4.5
4.7
6.23
5.98
mmol/l
0.94
177
1866
227
2232
1.17
0.27
46.9
19.0
37.61
40.02
%
8.63
222
2078
5
75
0.66
0.26
1.6
1.6
—
—
—
0
0
12
96
1.26
0.25
1.1
1.3
—
—
—
0
0
5
38
1.32
0.23
2.2
2.0
103.80
105.74
mmol/l
—
5
38
12
97
1.25
0.23
1.0
1.0
—
—
—
0
0
88
834
1.08
0.22
2.8
2.8
172.62
105.82
ug/l
2.08
82
765
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
158
1534
1.08
0.21
3.7
4.1
17.55
12.59
mm/h
1.92
136
1398
44
404
1.11
0.21
5.7
3.8
19.18
25.23
%
2.91
28
192
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
32
289
1.12
0.20
1.3
1.4
—
—
—
0
0
6
53
1.14
0.19
1.0
1.2
4.38
3.91
mmol/l
—
6
48
7
60
1.17
0.18
1.9
1.6
—
—
—
0
0
56
529
1.08
0.15
1.4
1.6
22.11
20.97
nmol/l
0.26
47
462
7
89
0.78
0.14
3.1
1.3
—
—
—
0
0
25
274
0.90
0.14
4.0
4.8
32.61
32.52
%
0.01
18
185
71
681
1.06
0.12
3.5
3.6
8.20
7.97
mg/mmol
0.03
45
414
12
106
1.14
0.10
3.2
3.5
4.30
4.52
pmol/l
0.48
12
94
5
46
1.09
0.09
1.0
1.1
60.42
24.18
iu/l
—
5
37
6
58
1.04
0.08
1.0
1.3
561.00
519.92
mg/l
—
6
52
31
293
1.07
0.08
3.3
2.6
0.74
0.75
ug/l
0.02
25
190
89
881
1.02
0.02
1.9
2.1
91.62
96.82
pmol/l
0.42
46
431
42
412
1.02
0.01
1.2
1.3
0.96
1.70
u/ml
0.78
15
125
192
1914
1.01
0.00
5.3
4.9
2.07
2.58
mu/l
0.37
176
1744
11
111
0.99
0.00
1.1
1.2
109.82
185.85
u/ml
0.55
11
102
112
1115
1.01
0.00
2.6
2.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
51.66
—
0
5
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
212.46
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
5
55
0.91
-0.00
2.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_LEIOMYOSARCOMA – Leiomyosarcoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).